Lymerix is off the market

The Lyme vaccine Lymerix is off the market due to poor sales.

Many factors may have contributed to the low demand. Lymerix is expensive...used in just a few regions...and isn't very effective.

It has also gotten a lot of bad press.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote